These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 3014265)

  • 1. The EBV-hybridoma technique.
    Roder JC; Cole SP; Kozbor D
    Methods Enzymol; 1986; 121():140-67. PubMed ID: 3014265
    [No Abstract]   [Full Text] [Related]  

  • 2. Generation of human monoclonal antibodies by fusion of EBV-activated B cells to a human-mouse hybridoma.
    Foung SK; Engleman EG; Grumet FC
    Methods Enzymol; 1986; 121():168-74. PubMed ID: 3014266
    [No Abstract]   [Full Text] [Related]  

  • 3. Stabilizing antibody secretion of human Epstein Barr virus-activated B-lymphocytes with hybridoma formation by electrofusion.
    Perkins S; Foung SK
    Methods Mol Biol; 1995; 48():295-307. PubMed ID: 8528401
    [No Abstract]   [Full Text] [Related]  

  • 4. Bispecific monoclonal antibodies from hybrid hybridomas.
    Suresh MR; Cuello AC; Milstein C
    Methods Enzymol; 1986; 121():210-28. PubMed ID: 3724461
    [No Abstract]   [Full Text] [Related]  

  • 5. Establishment of hybridoma secreting human monoclonal antibody against hepatitis B virus surface antigen.
    Ichimori Y; Harada K; Hitotsumachi S; Tsukamoto K
    Biochem Biophys Res Commun; 1987 Feb; 142(3):805-12. PubMed ID: 3030301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rescue of human monoclonal antibody production from an EBV-transformed B cell line by fusion to a human-mouse hybridoma.
    Foung SK; Perkins S; Raubitschek A; Larrick J; Lizak G; Fishwild D; Engleman EG; Grumet FC
    J Immunol Methods; 1984 May; 70(1):83-90. PubMed ID: 6201562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single-step technique for selecting and cloning hybridomas for monoclonal antibody production.
    Davis JM
    Methods Enzymol; 1986; 121():307-22. PubMed ID: 3487692
    [No Abstract]   [Full Text] [Related]  

  • 8. An improved in vitro immunization procedure for the production of monoclonal antibodies.
    Boss BD
    Methods Enzymol; 1986; 121():27-33. PubMed ID: 3724466
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro immunization for the production of antigen-specific lymphocyte hybridomas.
    Reading CL
    Methods Enzymol; 1986; 121():18-27. PubMed ID: 3014268
    [No Abstract]   [Full Text] [Related]  

  • 10. Human T cell hybridomas specific for Epstein Barr virus-infected B lymphocytes.
    Lakow E; Tsoukas CD; Vaughan JH; Altman A; Carson DA
    J Immunol; 1983 Jan; 130(1):169-72. PubMed ID: 6292301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial cell growth supplements for promoting the growth of monoclonal antibody-producing hybridoma cells.
    Ransom JH
    Methods Enzymol; 1986; 121():293-5. PubMed ID: 3724467
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibody engineering, a strategy for the development of monoclonal antibodies.
    Schönherr OT; Houwink EH
    Antonie Van Leeuwenhoek; 1984; 50(5-6):597-623. PubMed ID: 6099095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of human anti-rubella monoclonal antibodies from human hybridomas constructed with antigen-specific Epstein-Barr virus transformed cell lines.
    Hilfenhaus J; Kanzy EJ; Köhler R; Willems WR
    Behring Inst Mitt; 1986 Jun; (80):31-41. PubMed ID: 3019293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methods for high frequency production of soluble antigen-specific hybridomas; specificities and affinities of the monoclonal antibodies obtained.
    Cianfriglia M; Mariani M; Armellini D; Massone A; Lafata M; Presentini R; Antoni G
    Methods Enzymol; 1986; 121():193-210. PubMed ID: 2425215
    [No Abstract]   [Full Text] [Related]  

  • 15. [A strategy for the production of human monoclonal antibodies].
    Chiba J
    Hum Cell; 1988 Mar; 1(1):31-6. PubMed ID: 2856441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current developments in hybridoma technology].
    Osterhaus AD; UytdeHaag AG
    Tijdschr Diergeneeskd; 1985 Oct; 110(20):835-9. PubMed ID: 3878011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative phenotypic analysis of available human hybridoma fusion partners.
    Kozbor D; Roder JC; Sierzega ME; Cole SP; Croce CM
    Methods Enzymol; 1986; 121():120-40. PubMed ID: 3014264
    [No Abstract]   [Full Text] [Related]  

  • 18. Facilitated cell fusion for hybridoma production.
    Conrad MK; Lo MM
    Methods Enzymol; 1990; 184():641-53. PubMed ID: 2167431
    [No Abstract]   [Full Text] [Related]  

  • 19. An extreme strategy for the production of hybridoma.
    Golestani R; Pourfathollah AA; Moazzeni SM
    Hybridoma (Larchmt); 2009 Apr; 28(2):139-44. PubMed ID: 19249989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The high efficiency, human B cell immortalizing heteromyeloma CB-F7. Production of human monoclonal antibodies to human immunodeficiency virus.
    Grunow R; Jahn S; Porstmann T; Kiessig SS; Steinkellner H; Steindl F; Mattanovich D; Gürtler L; Deinhardt F; Katinger H
    J Immunol Methods; 1988 Feb; 106(2):257-65. PubMed ID: 2828478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.